Skip to main content

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

CymaBay Therapeutics

Start Date

June 8, 2021

End Date

May 31, 2025
 

Administered By

Medicine, Gastroenterology

Awarded By

CymaBay Therapeutics

Start Date

June 8, 2021

End Date

May 31, 2025